Generative AI Policy

GENERATIVE AI POLICY

INNOVATION JOURNAL OF PHARMACEUTICAL SCIENCE (INJOPHARS)

1. Introduction

INNOVATION JOURNAL OF PHARMACEUTICAL SCIENCE (INJOPHARS) recognizes that Generative Artificial Intelligence (AI) and AI-assisted technologies can support academic writing, research, and scholarly communication. However, their use must be responsible, transparent, and consistent with academic integrity and publication ethics.

This policy establishes guidelines for authors, editors, and reviewers regarding the appropriate use and disclosure of generative AI tools throughout the manuscript preparation, evaluation, and publication processes.

2. Policy for Authors

Authors may use generative AI tools to assist with specific aspects of manuscript preparation, provided that such use does not compromise the originality, accuracy, validity, or integrity of the research.

Permitted uses may include:

  • Language improvement, grammar correction, and spelling checks.
  • Improving sentence clarity, readability, and academic style.
  • Assisting with translation and language editing.
  • Supporting the organization or summarization of information, subject to verification by the authors.
  • Assisting with coding or other technical tasks, provided that the resulting work is checked and validated by the authors.

Authors remain fully responsible for the entire manuscript, including all content generated or modified with the assistance of AI tools. AI-generated information must be critically reviewed and independently verified before submission.

3. Disclosure of AI Use

Authors must disclose the use of generative AI tools when these tools have contributed to the development or substantive revision of the manuscript. The disclosure should identify the tool used, its purpose, and the relevant part of the manuscript or research process.

Disclosure is generally not required for basic spelling, grammar, or reference-management tools that do not generate substantive manuscript content. When in doubt, authors are encouraged to disclose the use of the tool.

Suggested AI Use Disclosure Statement

"During the preparation of this manuscript, the authors used [name of AI tool] for [specific purpose]. The authors subsequently reviewed, verified, and edited the generated content and take full responsibility for the final published work."

4. Prohibited and Unacceptable Uses

The following uses of generative AI are not acceptable:

  • Generating or manipulating research data, results, images, or findings and presenting them as genuine without appropriate disclosure and verification.
  • Creating fabricated references, citations, sources, or research evidence.
  • Producing misleading, inaccurate, or unsupported scientific claims.
  • Using AI-generated content to conceal plagiarism, duplicate publication, or other forms of research misconduct.
  • Submitting AI-generated material without appropriate human review and taking responsibility for its accuracy.
  • Using AI tools to misrepresent authorship, research contributions, or the actual research process.

Any AI-assisted content must comply with applicable ethical, legal, copyright, and research integrity requirements.

5. Authorship and Accountability

Generative AI tools, chatbots, and other AI systems cannot be listed as authors or co-authors of manuscripts submitted to INJOPHARS. Authorship is reserved for individuals who can take responsibility for the work and meet the journal's authorship requirements.

Human authors are responsible for the accuracy, originality, integrity, and ethical compliance of all submitted content, including material produced with AI assistance.

6. Research Data, Confidentiality, and Privacy

Authors must ensure that the use of AI tools does not violate confidentiality, data protection, intellectual property rights, or research ethics requirements. Sensitive personal information, confidential research data, unpublished findings, and identifiable patient information must not be entered into publicly accessible AI platforms unless appropriate authorization and safeguards are in place.

Authors conducting pharmaceutical, clinical, or health-related research must pay particular attention to patient confidentiality, informed consent, and applicable data protection requirements.

7. Policy for Editors

Editors may use AI-assisted tools for limited administrative or editorial support, provided that confidentiality, impartiality, and editorial independence are maintained.

  • Editors must not rely solely on AI-generated assessments to make editorial decisions.
  • Editorial decisions must be based on scholarly merit, peer-review reports, journal policies, and human judgment.
  • Editors must protect unpublished manuscripts and confidential information from unauthorized disclosure to AI systems.
  • Editors must assess disclosed AI use when relevant to research integrity and publication ethics.

8. Policy for Reviewers

Reviewers must maintain the confidentiality of all manuscripts and review materials. Manuscript content, unpublished research findings, and confidential information must not be uploaded to external generative AI tools or services without appropriate authorization.

Reviewers remain responsible for the accuracy, originality, fairness, and scholarly quality of their review reports. AI tools must not replace the reviewer's independent academic judgment or be used to generate unsupported evaluations.

9. AI Detection and Editorial Assessment

INJOPHARS may consider appropriate screening tools or editorial assessments when evaluating potential undisclosed or inappropriate AI use. However, AI-detection results are not definitive evidence of misconduct and must not be used as the sole basis for rejecting a manuscript or making allegations against an author.

Any concerns will be assessed by the editorial team through a fair and contextual evaluation, taking into account the manuscript, the authors' explanations, and relevant publication ethics principles.

10. Handling Non-Compliance

Failure to disclose relevant AI use, misuse of AI-generated content, or the presentation of fabricated or misleading material may be treated as a potential breach of publication ethics.

Depending on the nature and severity of the issue, the editorial team may request clarification, require manuscript corrections, reject the submission, or take appropriate post-publication action in accordance with the journal's Publication Ethics and Malpractice Policy.

Commitment to Responsible AI Use

INJOPHARS supports the responsible use of emerging technologies while maintaining human accountability, research integrity, transparency, and trust in scholarly publishing.

INJOPHARS – INNOVATION JOURNAL OF PHARMACEUTICAL SCIENCE

Published by PT. IRMEX DIGITAL AKADEMIKA

© 2026 INJOPHARS. All Rights Reserved.